{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:22:19Z","timestamp":1754194939703},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:00:00Z","timestamp":1537142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11926-018-0779-4","type":"journal-article","created":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T07:55:50Z","timestamp":1537170950000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differentiating Disease Flare From Infection: A Common Problem in Rheumatology. Do 18F-FDG PET\/CT Scans and Novel Biomarkers Hold The Answer?"],"prefix":"10.1007","volume":"20","author":[{"given":"Elizabeth","family":"Mabey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,17]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-196102000-00001","volume":"40","author":"RG Petersdorf","year":"1961","unstructured":"Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1\u201330.","journal-title":"Medicine"},{"key":"779_CR2","first-page":"35","volume":"11","author":"DT Durack","year":"1991","unstructured":"Durack DT, Street AC. Fever of unknown origin \u2013 reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35\u201351.","journal-title":"Curr Clin Top Infect Dis"},{"key":"779_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/MD.0b013e31802fe858","volume":"86","author":"CP Bleeker-Rovers","year":"2007","unstructured":"Bleeker-Rovers CP, Vos FJ, de Kleijn EM, et al. A prospective multi-centre study on fever of unknown origin: the yield of a structured diagnostic protocol. Medicine. 2007;86:26\u201338.","journal-title":"Medicine"},{"issue":"1","key":"779_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/annrheumdis-2017-211687","volume":"77","author":"Verena Sch\u00f6nau","year":"2017","unstructured":"Sch\u00f6nau V, Vogel K, Englbrecht M, et al. The value of 18F-FDG-PET\/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77:70\u20137.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"779_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0033-8389(05)70319-5","volume":"39","author":"D Delbeke","year":"2001","unstructured":"Delbeke D, Martin WH. Positron emission tomography imaging in oncology. Radiol Clin N Am. 2001;39(5):883\u2013917.","journal-title":"Radiol Clin N Am"},{"key":"779_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.semnuclmed.2013.04.005","volume":"43","author":"IJ Kouijzer","year":"2013","unstructured":"Kouijzer IJ, Bleeker-Rovers CP, Oyen WJ. FDG-PET in fever of unknown origin. Semin Nucl Med. 2013;43:333\u20139.","journal-title":"Semin Nucl Med"},{"issue":"5","key":"779_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S1473-3099(01)00146-3","volume":"1","author":"W Becker","year":"2001","unstructured":"Becker W, Meller J. The role of nuclear medicine in infection and inflammation. Lancet Infect Dis. 2001;1(5):326\u201333.","journal-title":"Lancet Infect Dis"},{"key":"779_CR8","unstructured":"\u2022 Bharucha T, Rutherford A, Skeoch S, et al. Diagnostic yield of FDG-PET\/CT in fever of unknown origin: a systematic review, meta-analysis and dephi exercise. Clin Radiol. 2017. Available from: 10.1016\/j.crad.2017.04.014 [Accessed 22nd January 2018]. This systematic review evaluates available evidence for the use of FDG-PET\/CT in fever of unknown origin and discusses cost vs. benefits."},{"key":"779_CR9","doi-asserted-by":"crossref","unstructured":"\u2022 Imfeld S, Rottenburger C, Schegk E, et al. [18F] FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis \u2013 lessons from a vasculitis clinic. Eur Heart J Cardiovasc Imaging. 2017. This article evaluates the value of FDG-PET\/CT in giant cell arteritis and discusses where false positive results may be obtained.","DOI":"10.1093\/ehjci\/jex259"},{"issue":"1","key":"779_CR10","first-page":"35","volume":"48","author":"J Meller","year":"2007","unstructured":"Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET\/CT in fever of unknown origin. J Nucl Med. 2007;48(1):35\u201345.","journal-title":"J Nucl Med"},{"key":"779_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3899\/jrheum.120171","volume":"39","author":"A Clifford","year":"2012","unstructured":"Clifford A, Burrell S, Hanly JG. Positron emission tomography\/computed tomography for the diagnosis and assessment of giant cell arteritis: when to consider it and why. J Rheumatol. 2012;39:1909\u201311.","journal-title":"J Rheumatol"},{"key":"779_CR12","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","volume":"35","author":"G Myklebust","year":"1996","unstructured":"Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatic and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis\u2019. Br J Rheumatol. 1996;35:1161\u20138.","journal-title":"Br J Rheumatol"},{"key":"779_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00005792-198503000-00002","volume":"64","author":"S Hall","year":"1985","unstructured":"Hall S, Barr W, Lie JT, et al. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985;64:89\u201399.","journal-title":"Medicine"},{"issue":"10","key":"779_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10067-011-1828-9","volume":"30","author":"G Treglia","year":"2011","unstructured":"Treglia G, Mattoli MV, Leccisotti L, et al. Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review. Clin Rheumatol. 2011;30(10):1265\u201375.","journal-title":"Clin Rheumatol"},{"key":"779_CR15","first-page":"2011","volume":"3","author":"N Erg\u00fcl","year":"2011","unstructured":"Erg\u00fcl N, Cermik TF. FDG-PET or PET\/CT in fever of unknown origin: the diagnostic role of underlying primary disease. Int J Mol Imaging. 2011;3:2011.","journal-title":"Int J Mol Imaging"},{"issue":"6","key":"779_CR16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1445-2197.2005.03399.x","volume":"75","author":"EW Chong","year":"2005","unstructured":"Chong EW, Robertson AJ. Is temporal artery biopsy a worthwile procedure? ANZ J Surg. 2005;75(6):388\u201391.","journal-title":"ANZ J Surg"},{"issue":"14","key":"779_CR17","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1097\/MD.0000000000000622","volume":"94","author":"M Soussan","year":"2015","unstructured":"Soussan M, Nicolas P, Schramm C, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine. 2015;94(14):e622.","journal-title":"Medicine"},{"issue":"3","key":"779_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/art.40379","volume":"70","author":"Peter C. Grayson","year":"2018","unstructured":"\u2022 Grayson PC, Alehashemi S, Bagheri AA, et al. Positron emission tomography as an imaging biomarker in a prospective longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheum. 2017. \n                      https:\/\/doi.org\/10.1002\/art.40379\n                      \n                     This study evaluates the use of FDG-PET\/CT in patients with large vessel vasculitis as compared to patients with vasculitis mimics.","journal-title":"Arthritis & Rheumatology"},{"key":"779_CR19","doi-asserted-by":"crossref","unstructured":"Glaudemans AW, de Vries EF, Galli F, et al. The use of F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases. Clin Dev Immunol. 2013","DOI":"10.1155\/2013\/623036"},{"issue":"3","key":"779_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.7861\/clinmedicine.15-3-288","volume":"15","author":"J Galloway","year":"2015","unstructured":"Galloway J, Cope AP. The ying and yang of fever in rheumatic disease. Clin Med. 2015;15(3):288\u201391.","journal-title":"Clin Med"},{"issue":"4","key":"779_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3109\/14397595.2013.850998","volume":"24","author":"H Yamashita","year":"2014","unstructured":"Yamashita H, Kubota K, Takahashi Y, et al. Clinical value of 18F-fluoro-deoxyglucose positron emission tomography\/computed tomography in patients with adult-onset Still\u2019s disease: a seven-case series and review of the literature. Mod Rheumatol. 2014;24(4):645\u201350.","journal-title":"Mod Rheumatol"},{"issue":"12","key":"779_CR22","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s10067-015-2901-6","volume":"34","author":"MJ Dong","year":"2015","unstructured":"Dong MJ, Wang CQ, Zhao K, et al. 18F-FDG PET\/CT in patients with adult-onset Still\u2019s disease. Clin Rheumatol. 2015;34(12):2047\u201356.","journal-title":"Clin Rheumatol"},{"key":"779_CR23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/0961203310393378","volume":"20","author":"N Firooz","year":"2011","unstructured":"Firooz N, Albert DA, Wallace DJ, et al. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus. 2011;20:588\u201397.","journal-title":"Lupus"},{"key":"779_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1741-7015-9-107","volume":"9","author":"P Schuetz","year":"2011","unstructured":"Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:197.","journal-title":"BMC Med"},{"issue":"2","key":"779_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/rheumatology\/keu416","volume":"54","author":"MM Shaikh","year":"2014","unstructured":"Shaikh MM, Hermans LE, van Laar JM. Is serum procalcitonin measurement a useful addition to a rheumatologist\u2019s repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections. Rheumatology. 2014;54(2):231\u201340.","journal-title":"Rheumatology"},{"key":"779_CR26","first-page":"123","volume":"24","author":"CA Scire","year":"2006","unstructured":"Scire CA, Cavagna L, Perotti C, et al. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheumatol. 2006;24:123\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"779_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10096-012-1812-6","volume":"32","author":"CJ Shen","year":"2013","unstructured":"Shen CJ, Wu MS, Lin KH, et al. The use of procalcitonin in the diagnosis of bone and joint infections: a systemic review and meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:807\u201314.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"779_CR28","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3899\/jrheum.111601","volume":"39","author":"H Sato","year":"2012","unstructured":"Sato H, Tanabe N, Murasawa A, et al. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis. J Rheumatol. 2012;39(8):1517\u201323.","journal-title":"J Rheumatol"},{"issue":"4","key":"779_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3899\/jrheum.111044","volume":"39","author":"HA Kim","year":"2012","unstructured":"Kim HA, Jeon JY, An JM, et al. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8\/A9 and procalcitonin. J Rheumatol. 2012;39(4):728\u201334.","journal-title":"J Rheumatol"},{"issue":"1","key":"779_CR30","first-page":"114","volume":"35","author":"K Tamaki","year":"2008","unstructured":"Tamaki K, Kogata Y, Sugiyama D, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheumatol. 2008;35(1):114\u20139.","journal-title":"J Rheumatol"},{"key":"779_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5847\/wjem.j.issn.1920-8642.2014.01.002","volume":"5","author":"Q Zou","year":"2014","unstructured":"Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med. 2014;5:16\u20139.","journal-title":"World J Emerg Med"},{"key":"779_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jiac.2013.07.005","volume":"20","author":"S Endo","year":"2014","unstructured":"Endo S, Suzuki Y, Takahashi G, et al. Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis; a multicenter prospective study. J Infect Chemother. 2014;20:30\u20134.","journal-title":"J Infect Chemother"},{"key":"779_CR33","doi-asserted-by":"crossref","unstructured":"\u2022 Tsujimoto K, Hata A, Fujita M, et al. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis. Int J Rheum Dis. 2016. This article compares the use of presepsin and procalcitonin in patients with rheumatoid arthritis and systemic infection.","DOI":"10.1111\/1756-185X.12899"},{"issue":"4","key":"779_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1080\/14397595.2016.1246119","volume":"27","author":"S Tsuji","year":"2017","unstructured":"Tsuji S, Kitatoube A, Kikuchi-Taura A, et al. Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection. Mod Rheumatol. 2017;27(4):718\u201320.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"779_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/cid\/civ286","volume":"61","author":"M Ettinger","year":"2015","unstructured":"\u2022 Ettinger M, Calliess T, Kielstein JT, et al. Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection, and high-grade septic failure. Clin Infect Dis. 2015;61(3):332\u201341 This article compares different biomarkers in aseptic vs. septic joint pathology and concludes that combinations of biomarkers are superior to any one alone.","journal-title":"Clin Infect Dis"},{"key":"779_CR36","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1007\/s11999-010-1451-0","volume":"468","author":"MA Buttaro","year":"2010","unstructured":"Buttaro MA, Tanoira I, Comba F, et al. Combining C-reactive protein and interleukin-6 may be useful to detect periprosthetic hip infection. Clin Orthop Relat Res. 2010;468:3263\u20137.","journal-title":"Clin Orthop Relat Res"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0779-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0779-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T03:33:52Z","timestamp":1589945632000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0779-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,17]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0779-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,17]]},"assertion":[{"value":"17 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"70"}}